322 studies found for:    Open Studies | "Macular Degeneration"
Show Display Options
Rank Status Study
21 Recruiting Genetic Factors in Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention:
22 Recruiting Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration.
Condition: Neovascular Age-related Macular Degeneration
Intervention: Drug: Aflibercept (EYLEA)
23 Not yet recruiting Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration
Condition: Wet Age-related Macular Degeneration
Interventions: Drug: Bevacizumab;   Drug: Ranibizumab
24 Recruiting Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes
Condition: Age Related Macular Degeneration
Intervention: Drug: Ranibizumab
25 Recruiting S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000
Conditions: Cataract;   Macular Degeneration
Interventions: Drug: selenium;   Drug: vitamin E;   Drug: vitamin E placebo;   Drug: selenium placebo
26 Recruiting Low Vision Depression Prevention Trial for Age Related Macular Degeneration
Conditions: Age-related Macular Degeneration;   Depression
Interventions: Behavioral: BA-LVR;   Behavioral: ST-LVR
27 Recruiting Intravitreal Bone Marrow-Derived Stem Cells in Patients With Advanced Age-related Macular Degeneration
Condition: Age Related Macular Degeneration
Intervention: Other: intravitreal injection of autologous bone marrow stem cells
28 Recruiting Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration
Condition: Dry Macular Degeneration
Intervention: Biological: Adipose Derived Stem Cells
29 Unknown  Intravitreal Bevacizumab for Age-Related Macular Degeneration
Condition: Age Related Macular Degeneration
Intervention: Drug: bevacizumab intravitreal injection
30 Recruiting Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Conditions: Stargardt's Macular Dystrophy;   Fundus Flavimaculatus;   Juvenile Macular Dystrophy
Intervention: Biological: MA09-hRPE
31 Recruiting Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Device: Telescope prosthesis;   Device: WA-NG Telescope Prothesis
32 Recruiting Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Device: Telescope prosthesis;   Device: WA-NG Telescope Prothesis
33 Recruiting Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration
Condition: Age-related Macular Degeneration
Intervention: Drug: CLG561
34 Recruiting Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration
Condition: Wet Age-related Macular Degeneration
Intervention: Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
35 Unknown  Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab
36 Recruiting A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention: Drug: DE-120
37 Recruiting Laser Intervention in Early Age-Related Macular Degeneration Study
Condition: Age-related Macular Degeneration
Intervention: Device: 2RT nanosecond laser
38 Recruiting Non-exudative Age-related Macular Degeneration
Condition: Non-exudative Age-related Macular Degeneration
Intervention:
39 Unknown  Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration
Conditions: Macular Degeneration;   Visual Acuity
Intervention: Drug: Ranibizumab
40 Recruiting Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
Conditions: Geographic Atrophy;   Age-related Macular Degeneration
Interventions: Drug: LFG316;   Drug: Sham;   Drug: LFG316 Lower dose

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years